VitaNova Life Sciences (VNOV) Accounts Payables (2023 - 2026)

VitaNova Life Sciences' (VNOV) quarterly Accounts Payables came in at $208813.0 in Q2 2026, up 91.61% on a QoQ basis from $108978.0 in Q1 2026.

VitaNova Life Sciences (VNOV) Accounts Payables (2023 - 2026) Analysis & Trends

VitaNova Life Sciences (VNOV) has 4 years of Accounts Payables data on file, last reported at $208813.0 in Q2 2026.

Quarterly Accounts Payables changed N/A year-over-year to $208813.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $208813.0 (changed N/A YoY) and the FY2026 annual result came in at $208813.0, changed N/A from the prior year.
Accounts Payables climbed to $208813.0 in Q2 2026, from $108978.0 in the prior quarter.
In the past five years, Accounts Payables ranged from a high of $208813.0 in Q2 2026 to a low of $51843.0 in Q2 2023.
A 4-year average of $97229.9 and a median of $69375.0 in 2024 frame the typical range for Accounts Payables.
The widest YoY moves for Accounts Payables: up 142.81% in 2025, down 0.27% in 2025.
Tracing VNOV's Accounts Payables over 4 years: stood at $51843.0 in 2023, then soared by 33.82% to $69375.0 in 2024, then surged by 142.81% to $168450.0 in 2025, then increased by 23.96% to $208813.0 in 2026.
The last three Accounts Payables figures came in at $208813.0 (Q2 2026), $108978.0 (Q1 2026), and $168450.0 (Q4 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Mckesson	102.57 Bn	97.41 Bn	3.69 Bn	63.73 Bn
2	Cencora	61.35 Bn	58.53 Bn	3.61 Bn	54.70 Bn
3	Cardinal Health	54.15 Bn	49.30 Bn	2.56 Bn	38.28 Bn
4	Henry Schein	10.05 Bn	9.89 Bn	1.10 Bn	1.14 Bn
5	Akso Health	671.90 Mn	671.70 Mn	-	-
6	Edap Tms	154.62 Mn	133.07 Mn	7.34 Mn	-
7	Accendra Health	90.69 Mn	83.04 Mn	263.41 Mn	352.80 Mn
8	111	31.31 Mn	-27.44 Mn	18.18 Mn	175.78 Mn
9	Cosmos Health	13.28 Mn	10.84 Mn	1.51 Mn	13.68 Mn
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	208,813.00

Download Data